Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 695,420 | 730,518 | 702,468 | 701,780 | 659,191 |
| Cost of Goods | 439,529 | 467,645 | 432,910 | 451,833 | 421,131 |
| Gross Profit | 255,891 | 262,873 | 269,558 | 249,947 | 238,060 |
| Operating Expenses | 156,073 | 187,725 | 181,659 | 155,310 | 248,937 |
| Operating Income | 100,347 | 75,793 | 88,809 | 95,470 | -10,746 |
| Interest Expense | 56,939 | 61,662 | 65,511 | 65,719 | 65,703 |
| Other Income | -5,922 | -29,450 | -7,875 | -9,346 | 927 |
| Pre-tax Income | 37,486 | -15,319 | 15,423 | 20,405 | -75,522 |
| Income Tax | 12,868 | 5,423 | 3,666 | 3,618 | 6,156 |
| Net Income Continuous | 24,618 | -20,742 | 11,757 | 16,787 | -81,678 |
| Minority Interests | 12,423 | 10,339 | 11,913 | 10,793 | 9,965 |
| Net Income | $12,195 | $-31,081 | $-156 | $5,994 | $-91,643 |
| EPS Basic Total Ops | 0.04 | -0.10 | 0.00 | 0.02 | -0.30 |
| EPS Basic Continuous Ops | 0.08 | -0.07 | 0.04 | 0.05 | -0.27 |
| EPS Diluted Total Ops | 0.04 | -0.10 | 0.00 | 0.02 | -0.30 |
| EPS Diluted Continuous Ops | 0.08 | -0.06 | 0.04 | 0.05 | -0.27 |
| EPS Diluted Before Non-Recurring Items | 0.19 | 0.10 | 0.15 | N/A | N/A |
| EBITDA(a) | $167,317 | $148,740 | $155,798 | $158,491 | $51,585 |